// App-Quantinova.ai

129 : Differential effect of body mass index (BMI) on outcomes of patients treated with docetaxel in prostate cancer: An exploratory analysis.

Researchers

Presenter

  • Saurav Verma

Principal Investigators

  • Ranjit Kumar Sahoo

  • Prabhjot Singh

  • Brusabhanu Nayak

  • KP Haresh

  • Atul Batra

Medical Centers

  • All India Institute of Medical Sciences, New Delhi, India

Locations

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

  • Obesity

  • Solid malignancies

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Body mass index

Drug/Treatment

  • Zibotentan

  • Docetaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • NCT00617669

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved